Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia.

Bibliographic Details
Title:	Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia.
Authors:	Tedeschi, Alessandra ^, Rossi, Davide, Coscia, Marta ^, Vismara, Eleonora ^, Petrizzi, Valeria Belsito ^, Orlandi, Ester ^, Cascavilla, Nicola ^, Scarfò, Lydia ^, Motta, Marina, Vitale, Candida ^, Ricci, Francesca ^, De Paoli, Lorenzo ^, D'Arco, Alfonso Maria ^, Gallamini, Andrea, Gaidano, Gianluca, Morra, Enrica, Massaia, Massimo ^, Montillo, Marco
Source:	In Blood 16 November 2012 120(21):2898-2898
Database:	ScienceDirect